Accès ouvert
2023
article
OpenAlex
Mark Edwards, Gordon Forbes, Neil Walker, Dion Morton et autres
INTRODUCTION: Postoperative morbidity and mortality in patients undergoing major emergency gastrointestinal surgery are a major burden on healthcare systems. Optimal management of perioperative intravenous fluids may reduce mortality rates and improve outcomes from surgery. Previous small trials of cardiac-output guided haemodynamic therapy …
gb
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Philip L. Cohen, Robert Cheek, Robert A. Eisenberg, Suzanne C. Morris
A chronic graft-versus-host reaction (GVH) induced in nonautoimmune mice causes a syndrome that closely resembles SLE. In this model, donor T cells react against incompatible host Ia structures and generate excessive help, which activates a subpopulation of self-reactive B cells. We have …
us
(code pays fourni par la source)
2009
conference-abstract
OpenAlex
L. Chen, Howard D. Homesley, Dennis R. Scribner, Guilherme Cantuaria et autres
5566 Background: We previously reported the performance of biomarker combinations that displayed utility in identifying ovarian cancer from normal sera and in monitoring for disease recurrence. In this study, we evaluated the performance of a subset of these markers in differentiating ovarian …
us
(code pays fourni par la source)
2009
conference-abstract
OpenAlex
Jeffrey P. Baker, Robert Cheek, John Groelke, Qin He et autres
Ovarian cancer, the fourth leading cause of cancer death, is diagnosed in more than 22,000 women in the U.S each year. The only established biomarker for ovarian cancer is CA125, which shows low sensitivity for detecting early stage ovarian cancer. The prognosis …
2008
article
OpenAlex
Laura J. Havrilesky, Clark M. Whitehead, Jennifer M. Rubatt, Robert Cheek et autres
us
(code pays fourni par la source)
2007
article
OpenAlex
Robert Cheek, Lorraine King, Malena Sansbury, Qin He et autres
2669 The 5 year survival rate for epithelial ovarian cancer (EOC) depends greatly on the stage of the disease at the time of diagnosis; increased survival is associated with early detection (i.e. Stage 1 or 2). However, the vast majority of ovarian …
Accès ouvert
1998
article
OpenAlex
Jory P. Weintraub, Virginia Godfrey, P A Wolthusen, Robert Cheek et autres
The lpr mutation in mice results in premature termination of transcription of the gene encoding the apoptosis-signaling receptor Fas. As a result, lpr mice develop severe lymphoproliferation and lupus-like autoantibodies. Growing evidence suggests that the lpr mutation is "leaky" and that low …
us
(code pays fourni par la source)
1997
article
OpenAlex
V.N. Kakkanaiah, Eric S. Sobel, Glen C. MacDonald, Robert Cheek et autres
Anti-Sm Abs are specific markers of human systemic lupus erythematosus (SLE) and of murine models of this disease. In humans, anti-Sm Abs are mostly IgG1, and in MRL/lpr mice, IgG2a; both are T-dependent isotypes. Other lpr strains, such as B6/lpr, do not …
us
(code pays fourni par la source)
1996
article
OpenAlex
E A Creech, Danièle Nakul‐Aquaronne, Elizabeth A. Reap, Robert Cheek et autres
The MHC exerts an important influence on systemic autoimmune disease. In C57BL/6-lpr/lpr (B6/lpr) mice, substitution of the H-2d instead of the H-2b MHC haplotype results in a global reduction in autoantibody levels. Since H-2d expresses both I-A and I-E, while H-2b expresses …
us
(code pays fourni par la source)
1994
article
OpenAlex
Eric S. Sobel, V.N. Kakkanaiah, M Kakkanaiah, Robert Cheek et autres
A central question in autoimmunity is the mechanism of T cell help for autoantibody production. For responses to exogenous Ag, T-B collaboration is restricted by MHC class II molecules. To determine whether T cell help that leads to autoantibodies in murine SLE …
us
(code pays fourni par la source)
1993
article
OpenAlex
Christopher G. Willett, Robert Cheek, Gretchen Warland, Paul C. Shellito et autres
1992
article
OpenAlex
Kent Lewandrowski, Robert Cheek, David M. Nathan, John E. Godine et autres
us
(code pays fourni par la source)